tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Erasca (ERAS)
NASDAQ:ERAS
US Market
ERAS
Erasca
RESEARCH TOOLSreports

Erasca (ERAS) Stock News & Sentiment

Compare
334 Followers
Erasca extends cash runway after upsized public offering
Premium
Company Announcements
Erasca extends cash runway after upsized public offering
5d ago
8K
ERAS
Erasca Announces Major Underwritten Public Equity Offering
Premium
Company Announcements
Erasca Announces Major Underwritten Public Equity Offering
12d ago
8K
ERAS
Erasca Highlights Accelerated Progress in RAS-Targeted Trials
Premium
Company Announcements
Erasca Highlights Accelerated Progress in RAS-Targeted Trials
23d ago
8K
ERAS
Erasca, Inc. Reports Q3 2025 Financial Results
Premium
Company Announcements
Erasca, Inc. Reports Q3 2025 Financial Results
3M ago
ERAS
Erasca, Inc. Advances with Promising Phase 1 Study on ERAS-4001
Premium
Company Announcements
Erasca, Inc. Advances with Promising Phase 1 Study on ERAS-4001
3M ago
ERAS
Erasca, Inc. Advances in Cancer Treatment with ERAS-0015 Study
Premium
Company Announcements
Erasca, Inc. Advances in Cancer Treatment with ERAS-0015 Study
3M ago
ERAS
Erasca’s SEACRAFT-2 Study: A Promising Step in Melanoma Treatment
Premium
Company Announcements
Erasca’s SEACRAFT-2 Study: A Promising Step in Melanoma Treatment
3M ago
ERAS
More ERAS News >

ERAS News on the Web

Erasca extends cash runway after upsized public offering
TipRanks News
Neutral
Erasca Shares Jump on Optimistic Drug Trial Outlook
TipRanks News
Bullish
Erasca price target raised to $12 from $5 at Guggenheim
TipRanks News
Bullish
Erasca (ERAS) Has a New Rating from Mizuho Securities
TipRanks News
Bullish
Erasca assumed with an Outperform at Mizuho
TipRanks News
Bullish
ERAS: HC Wainwright & Co. Raises Price Target to $15, Maintains Buy Rating | ERAS Stock News
GuruFocus News
Bullish
Stifel Nicolaus Reaffirms Their Buy Rating on Erasca (ERAS)
TipRanks News
Bullish
Erasca price target raised to $10 from $4 at Morgan Stanley
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
ERAS
Sector Average
Media Buzz
This Week1 articles
Weekly Average9 articles
News Sentiment
This Week50%
Sector Average73%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ERAS’s Media Buzz Sentiment?
1 articles about ERAS were published this week. In an average week, 9 articles are published.
    What is ERAS’s weekly average amount of articles?
    In an average week, 9 articles about ERAS are published.
      What is ERAS’s News Sentiment?
      50% of articles about ERAS were positive this week, compared to its sector average of 73%.
        Healthcare Stocks that are Trending in the News
        HOCPFHOYA
        QNCXQuince Therapeutics
        VREOFVireo Growth
        DVADaVita
        KRROKorro Bio
        Showing the stocks with the most bullish news sentiment over the past week